Maryland Oncology Hematology remains open while making accommodations for the health and safety of our patients. If you believe you have been exposed to COVID-19 or have symptoms of COVID-19 including fever, cough, sore throat or shortness of breath, please call our office before you arrive. Any patient that has traveled out of state, please call before your appointment for travel information and review our travel policy. Our Mt. Airy location is now open and Wheaton patients now call Rockville & Germantown. View more information.


Frederick Min, M.D.

Frederick Min, M.D.


Medical Oncology


Silver Spring
12210 Plum Orchard Dr #211 Silver Spring, MD 20904
Phone: 301-933-3216 (System Down) - Call Laurel Office 301-933-3216
Fax: 832-601-6868
View Map



Frederick Min, M.D.


Clinical Pharmacology & Oncology from NIH and Georgetown University Medical Center


Dr. Frederick Min has extensive experience as a clinical investigator and drug developer. After his internal medicine training from Cornell, he proceeded to combined Clinical Pharmacology and Oncology fellowship from NIH and Georgetown University Medical Center. He has published and presented numerous articles in ASCO, ASH, ASCPT and FDA meetings. He has led several Phase I clinical trials and regulatory science as clinical investigator including the approval of Treanda (Bendamustine). He has led multiple novel therapies in different stages in the US, Europe and Asia as Global Clinical Lead at Novartis as Senior Medical Director. With his extensive experience as a clinical investigator and drug developer, we believe he will bring our patients the most up to date and advanced therapies available. He is fluent in Korean.


Dr. Min was honored with multiple awards including the RISES award from Washington Adventist Hospital, Top doctor at Washingtonian, Patients Choice award and was named one of “America’s Top Oncologists” by the Consumers’ Research Council of America. He serves as clinical professor of medicine at Georgetown University Medical School.